KSG AGRO S.A. financials
KSG AGRO S.A.
2221005HTTH3XEY0HJ91 | Line item | 2023 | 2022 |
|---|---|---|
| Income statement | ||
| Revenue | $18.8M | $16.2M |
| Cost of sales | $15.4M | $17.6M |
| Gross profit | $483.0K | $3.2M |
| Operating profit (EBIT) | -$1.6M | $442.0K |
| Finance costs | $3.0M | $3.5M |
| Profit before tax | -$1.2M | -$1.7M |
| Income tax expense | $8.0K | $0 |
| Profit for the year | -$1.2M | -$1.7M |
| — attributable to owners | -$1.1M | -$1.5M |
| — attributable to NCI | -$73.0K | -$134.0K |
| Total comprehensive income | -$1.2M | -$4.3M |
| Per share | ||
| Basic EPS | $-0.07 | $-0.10 |
| Diluted EPS | $-0.07 | $-0.10 |
| Free cash flow / share | $13.12 | $-235.89 |
| Cash flow statement | ||
| Cash generated from operations | $4.1M | $323.0K |
| Net cash from operating activities | $1.5M | -$2.7M |
| Net cash from investing activities | -$3.0M | -$740.0K |
| Purchase of PP&E (capex) | $1.3M | $875.0K |
| Net cash from financing activities | $1.4M | $3.2M |
| Proceeds from borrowings | $16.7M | $4.7M |
| Repayments of borrowings | $15.3M | $1.5M |
| Lease liability payments | $0 | $14.0K |
| Net change in cash | -$58.0K | -$246.0K |
| Balance sheet | ||
| Total assets | $31.8M | $35.0M |
| Non-current assets | $15.9M | $17.5M |
| Property, plant & equipment | $10.4M | $10.6M |
| Right-of-use assets | $1.0M | $1.1M |
| Current assets | $15.9M | $17.6M |
| Inventories | $7.7M | $8.5M |
| Trade & other receivables | $1.3M | $2.8M |
| Cash & equivalents | $206.0K | $271.0K |
| Total equity | -$834.0K | -$12.5M |
| — attributable to owners | -$834.0K | -$12.4M |
| Non-controlling interests | $0 | -$18.0K |
| Non-current liabilities | $5.9M | $19.0M |
| Lease liabilities (non-current) | $848.0K | $881.0K |
| Current liabilities | $26.7M | $28.4M |
| Lease liabilities (current) | $1.5M | $1.1M |
| Derived metrics | ||
| Free cash flow | $197.0K | -$3.5M |
| Operating margin | -8.6% | 2.7% |
| Net margin | -6.2% | -10.4% |
| Return on equity | 139.2% | 13.5% |
| Cash conversion ratio | -1.30× | 1.59× |
| Capex coverage | 1.15× | -3.05× |
| Other reported items | ||
| Adjusted Weighted Average Shares | 0.0M | 0.0M |
| Adjustments For Decrease Increase In Biological Assets | $1.1M | $2.4M |
| Adjustments For Decrease Increase In Inventories | $840.0K | -$2.5M |
| Adjustments For Decrease Increase In Trade Account Receivable | -$163.0K | -$1.8M |
| Adjustments For Depreciation and Amortisation Expense | $1.2M | $1.4M |
| Adjustments For Finance Costs | $3.0M | $3.5M |
| Adjustments For Gain Loss On Disposal of Investments In Subsidiaries Joint Ventures and Associates | $926.0K | $9.9M |
| Adjustments For Gains Losses On Change In Fair Value Less Costs To Sell Biological Assets | -$2.9M | $4.6M |
| Adjustments For Impairment Loss Reversal of Impairment Loss Recognised In Profit Or Loss Inventories | -$77.0K | $689.0K |
| Adjustments For Impairment Loss Reversal of Impairment Loss Recognised In Profit Or Loss Property Plant and Equipment | -$17.0K | $795.0K |
| Adjustments For Increase Decrease In Trade Account Payable | -$3.5M | $4.4M |
| Adjustments For Interest Income | $355.0K | $0 |
| Adjustments For Unrealised Foreign Exchange Losses Gains | -$316.0K | $678.0K |
| Cash Flows From Used In Operations Before Changes In Working Capital | $5.7M | -$2.2M |
| Comprehensive Income Attributable To Noncontrolling Interests | -$73.0K | -$144.0K |
| Comprehensive Income Attributable To Owners of Parent | -$1.1M | -$4.2M |
| Current Advances | $939.0K | $748.0K |
| Current Biological Assets | $3.8M | $5.0M |
| Current Loans Received and Current Portion of Noncurrent Loans Received | $10.8M | $9.6M |
| Current Prepayments | $1.8M | $453.0K |
| Current Tax Assets Current | $444.0K | $220.0K |
| Current Tax Liabilities Current | $237.0K | $100.0K |
| Effect of Exchange Rate Changes On Cash and Cash Equivalents | -$7.0K | -$120.0K |
| Equity and Liabilities | $31.8M | $35.0M |
| Gains Losses On Initial Recognition of Biological Assets For Current Period | -$2.9M | $4.6M |
| Gains Losses Recognised When Control In Subsidiary Is Lost | $926.0K | $9.9M |
| Income Taxes Paid Refund Classified As Operating Activities | $125.0K | $0 |
| Increase Decrease Through Acquisition of Subsidiary | -$348.0K | -$3.2M |
| Increase Decrease Through Appropriation of Retained Earnings | $13.2M | — |
| Interest Paid Classified As Operating Activities | $2.4M | $3.0M |
| Issued Capital | $150.0K | $150.0K |
| Liabilities | $32.6M | $47.5M |
| Noncurrent Biological Assets | $4.4M | $5.8M |
| Noncurrent Portion of Noncurrent Loans Received | $5.0M | $18.2M |
| Other Comprehensive Income | -$47.0K | -$2.6M |
| Other Comprehensive Income Net of Tax Exchange Differences On Translation | -$47.0K | -$2.6M |
| Other Current Financial Assets | $642.0K | $310.0K |
| Other Current Liabilities | $8.5M | $7.8M |
| Other Gains Losses | $2.5M | -$8.5M |
| Proceeds From Disposal of Noncurrent Assets Or Disposal Groups Classified As Held For Sale and Discontinued Operations | -$24.0K | -$16.0K |
| Proceeds From Disposals of Property Plant and Equipment Intangible Assets Other Than Goodwill Investment Property and Other Noncurrent Assets | $103.0K | $151.0K |
| Purchase of Biological Assets | $1.8M | $0 |
| Reserve of Exchange Differences On Translation | -$11.6M | -$11.2M |
| Retained Earnings | -$26.7M | -$38.7M |
| Selling General and Administrative Expense | $2.1M | $2.7M |
| Share Premium | $37.4M | $37.4M |
| Trade and Other Current Payables To Trade Suppliers | $4.8M | $9.1M |
| Treasury Shares | $112.0K | $112.0K |
| Weighted Average Shares | 0.0M | 0.0M |
Every line item above is a fact tagged in KSG AGRO S.A.'s annual report
filed in the European Single Electronic Format (ESEF) under the IFRS
taxonomy (ifrs-full) — the income statement, balance sheet
and cash-flow statement as the filer reported them. Values are shown
as-is, in the reporting currency (USD), without
rescaling; the row labels map to the underlying concept name (e.g.
Revenue → ifrs-full:Revenue, Operating profit →
ifrs-full:ProfitLossFromOperatingActivities, Diluted EPS →
ifrs-full:DilutedEarningsLossPerShare), and any concept
without a curated label is shown under “Other reported items” with its
de-camel-cased tag name. Only consolidated, default-member facts are
shown (segment / dimensional breakdowns are excluded).
“Derived metrics” (free cash flow, margins, ROE, …) are computed from those facts by the same model the U.S. financials pages use — not tagged by the filer.
Source: machine-readable OIM xBRL-JSON aggregated by filings.xbrl.org (XBRL International). Entity identity is resolved by LEI via the public-domain GLEIF register. This is reference data, not investment advice.